Israel launches ‘anti-dumping’ probe into Canadian cannabis companies
Israel has opened an “anti-dumping investigation” concerning the importation of medical marijuana from Canada after finding “a causal link” between the imports […]
Category: Tilray
Cannabis operator Tilray trims loss to $46 million in quarter on record sales
Canadian cannabis producer Tilray Brands trimmed its loss to $46.2 million (61.6 million Canadian dollars) in the second quarter of its 2024 […]
Investment Strategies for Entering the European Cannabis Market
For U.S. venture capitalists (VCs), the burgeoning European cannabis market provides opportunities to break into the industry on the heels of adult-use […]
Is Tilray Stock a Buy Post Fiscal Q2 Results?
Canadian cannabis giant Tilray (NASDAQ:TLRY) announced its fiscal second quarter of 2022 results last week. The company reported net revenue of $155 […]
Aphria, Tilray to host April shareholder meetings about planned merger
Aphria and Tilray will host special shareholder meetings next month on the proposed merger between the cannabis producers, the companies said. The […]
Canada extends wage subsidy popular with cannabis producers
Canada’s government is extending a pandemic-related wage-subsidy program that has been tapped by more than a dozen federally regulated cannabis producers. The […]
Aphria-Tilray cannabis merger talks overcame pandemic pause, rival bidder and other hurdles, proxy reveals
On-again, off-again merger talks between rival cannabis producers Tilray and Aphria had their genesis in October 2019 when an unidentified investment bank […]
Canadian marijuana producer Tilray reports $271 million loss for year
Cannabis producer Tilray cut its annual loss to $271 million for 2020, an improvement from the Nanaimo, British Columbia company’s $321 million […]
Will GW’s multibillion-dollar sale ‘open floodgates’ to pharma-cannabis deal-making?
Jazz Pharmaceuticals’ planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making between pharma and medical […]
Cannabis M&A in the Post-COVID Era
After a slow start following a disappointing 2019, M&A in the cannabis space closed 2020 with a bang, with more than $600 […]